StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2023 - 07 - 25
1
2023 - 07 - 10
1
2022 - 10 - 10
1
2022 - 10 - 05
1
2022 - 04 - 25
1
2021 - 11 - 13
1
2021 - 11 - 12
1
2021 - 11 - 09
1
2021 - 10 - 18
1
2021 - 10 - 01
1
2021 - 09 - 28
1
2021 - 09 - 23
1
2021 - 06 - 21
1
2021 - 05 - 12
1
2021 - 03 - 10
1
Sector
Commercial services
1
Health technology
15
Tags
Advanced
2
America
1
Application
4
Approval
1
Asco
1
Awards
1
Biocapital
1
Biotech
2
Biotech-bay
4
Biotechnology
4
Bone
1
Breast
1
Business
1
Cancer
17
Cell
6
Companies
3
Conference
21
Congress
1
Drug
3
Events
3
Fda
3
Financial
11
Financial results
4
Food
3
Global
4
Grant
8
Granted
5
Grants
12
Immunotherapy
10
Iot
33
J.p. morgan healthcare conference
2
License
4
Lung
5
Lung cancer
3
Market
12
Meeting
4
Melanoma
14
N/a
105
Nasdaq
18
News
2
Novartis
2
Offering
4
People
4
Pharmaceutical
2
Pre-clinical
2
Presentation
3
Program
2
Report
4
Research
8
Results
18
Solid tumors
2
Submission
3
Technology
2
Therapeutics
12
Therapy
15
Treatment
4
Trial
3
Tumor
3
Update
6
Year
5
Entities
Abbott laboratories
22
Abbvie inc.
40
Abeona therapeutics inc.
21
Accuray incorporated
22
Actinium pharmaceuticals, inc.
16
Adaptimmune therapeutics plc
15
Amgen inc.
42
Anixa biosciences, inc.
16
Astellas pharma inc
23
Astrazeneca plc
32
Ati physical therapy inc - class a
38
Avrobio, inc.
23
Baxter international inc.
17
Biocardia, inc.
27
Biogen inc.
30
Biomarin pharmaceutical inc.
29
Biorestorative therapies, inc.
16
Bluebird bio, inc.
32
Brainsway ltd.
15
Bridgebio pharma, inc.
17
Bristol-myers squibb company
65
Celularity inc - class a
16
Charles river laboratories international, inc.
19
Crispr therapeutics ag
15
Eli lilly and company
88
Fate therapeutics, inc.
15
Fortress biotech, inc.
20
Genprex, inc.
29
Gilead sciences, inc.
52
Glaxosmithkline plc
24
Incyte corporation
37
Intellia therapeutics, inc.
17
Intra-cellular therapies inc.
33
Iovance biotherapeutics, inc.
15
Jaguar health, inc.
15
Johnson & johnson
103
Medtronic plc
30
Merck & company, inc.
31
Mustang bio, inc.
16
Neuronetics, inc.
35
Novartis ag
89
Ocugen, inc.
17
Orange
36
Orchard therapeutics plc
24
Pfizer, inc.
29
Poseida therapeutics, inc.
31
Precision biosciences, inc.
19
Regeneron pharmaceuticals, inc.
18
Regenxbio inc.
25
Rocket pharmaceuticals, inc.
16
Sanofi
113
Sarepta therapeutics, inc.
24
Sio gene therapies inc
25
Takeda pharmaceutical company limited
43
Taysha gene therapies, inc.
52
Thermo fisher scientific inc
26
Ultragenyx pharmaceutical inc.
18
Uniqure n.v.
36
Viewray, inc.
34
Voyager therapeutics, inc.
16
Symbols
CDMO
1
CLLS
1
CRL
1
IOVA
15
LEGN
1
Exchanges
Nasdaq
15
Nyse
1
Crawled Date
2023 - 07 - 25
1
2023 - 07 - 10
1
2022 - 10 - 10
1
2022 - 10 - 05
1
2022 - 04 - 25
1
2021 - 11 - 14
1
2021 - 11 - 12
1
2021 - 11 - 09
1
2021 - 10 - 19
1
2021 - 10 - 01
1
2021 - 09 - 28
1
2021 - 09 - 23
1
2021 - 06 - 21
1
2021 - 05 - 12
1
2021 - 03 - 10
1
Crawled Time
00:00
1
00:20
1
11:00
1
12:00
2
12:20
1
14:00
2
17:00
1
20:00
1
21:00
2
22:00
2
23:00
1
Source
www.biospace.com
4
www.globenewswire.com
10
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapy
entities :
Iovance biotherapeutics, inc.
save search
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer
Published:
2023-07-25
(Crawled : 20:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
59.52%
|
O:
0.28%
H:
2.53%
C:
-0.84%
lung
conference
world
cancer
tumor
therapy
Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
Published:
2023-07-10
(Crawled : 11:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
56.22%
|
O:
0.69%
H:
20.92%
C:
20.58%
lung
cancer
cell
therapy
Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy
Published:
2022-10-10
(Crawled : 12:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
15.76%
|
O:
-0.82%
H:
0.72%
C:
-10.73%
CLLS
|
$2.47
0.4%
12K
|
Health Technology
|
2.82%
|
O:
-0.81%
H:
0.0%
C:
-4.47%
therapy
Iovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Published:
2022-10-05
(Crawled : 12:20)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
13.1%
|
O:
-2.3%
H:
2.35%
C:
0.82%
melanoma
immunotherapy
meeting
therapy
Iovance Biotherapeutics to Present at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit
Published:
2022-04-25
(Crawled : 21:00)
- biospace.com/
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-30.49%
|
O:
1.04%
H:
0.0%
C:
0.0%
genetic
therapy
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Cancers at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-11-13
(Crawled : 00:20)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
immunotherapy
therapy
cancer
iot
Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-11-12
(Crawled : 22:00)
- biospace.com/
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-51.87%
|
O:
-2.55%
H:
0.0%
C:
0.0%
immunotherapy
lung cancer
therapy
cancer
iot
Iovance Biotherapeutics Announces Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Multiple Solid Tumors at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-11-09
(Crawled : 14:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-54.87%
|
O:
-0.36%
H:
4.65%
C:
-0.64%
immunotherapy
solid tumors
therapy
cancer
iot
Iovance Biotherapeutics to Host Conference Call and Webcast to Highlight Data at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2021-10-18
(Crawled : 00:00)
- biospace.com/
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-57.5%
|
O:
-0.41%
H:
0.38%
C:
-3.62%
immunotherapy
therapy
cancer
iot
conference
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapies Across Multiple Solid Tumors and Treatment Settings at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published:
2021-10-01
(Crawled : 14:00)
- biospace.com/
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-54.14%
|
O:
-0.69%
H:
9.02%
C:
7.59%
treatment
immunotherapy
solid tumors
therapy
cancer
iot
Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC) in the Philadelphia Navy Yard
Published:
2021-09-28
(Crawled : 22:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-54.06%
|
O:
0.93%
H:
2.01%
C:
-4.27%
therapy
iot
Iovance Biotherapeutics Initiates Clinical Supply of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy Manufactured at Iovance Cell Therapy Center (iCTC)
Published:
2021-09-23
(Crawled : 12:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-54.69%
|
O:
0.68%
H:
2.11%
C:
1.87%
therapy
iot
Global Cell and Gene Therapy Manufacturing Market Report 2021-2025: Expected Capacity Crunch, Investments for CGT Capacity Expansion, Events Driving Expansion for CGT Facilities and Infrastructure
Published:
2021-06-21
(Crawled : 17:00)
- prnewswire.com
CRL
|
$226.78
-0.34%
0.0%
410K
|
Commercial Services
|
-35.88%
|
O:
0.73%
H:
1.51%
C:
1.21%
LEGN
|
$46.14
-2.08%
-2.12%
1.2M
|
Health Technology
|
21.58%
|
O:
0.11%
H:
4.08%
C:
2.68%
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-54.36%
|
O:
-0.44%
H:
1.3%
C:
0.65%
CDMO
|
$6.41
-1.69%
-1.72%
790K
|
Health Technology
|
-72.39%
|
O:
-0.17%
H:
3.29%
C:
1.6%
expansion
gene therapy
therapy
gene therapies
Journal of Clinical Oncology Publishes Clinical Data for Cohort 2 in Iovance C-144-01 Study of Lifileucel TIL Therapy in Metastatic Melanoma
Published:
2021-05-12
(Crawled : 21:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-56.63%
|
O:
1.0%
H:
3.91%
C:
-5.05%
therapy
xin
Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual Meeting
Published:
2021-03-10
(Crawled : 23:00)
- globenewswire.com
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
-66.45%
|
O:
3.89%
H:
2.63%
C:
1.54%
therapy
cancer
research
iot
Gainers vs Losers
67%
33%
Top 10 Gainers
JOE
4
|
$54.88
1.22%
0.22%
210K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.